Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE2015.75105.65 (+5.53 %)
PREV CLOSE () 1910.10
OPEN PRICE () 1912.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 86374
TODAY'S LOW / HIGH ()1911.95 2101.00
52 WK LOW / HIGH ()1260.1 2101
NSE2003.8094 (+4.92 %)
PREV CLOSE() 1909.80
OPEN PRICE () 1915.90
BID PRICE (QTY) 2003.80 (24049)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1744754
TODAY'S LOW / HIGH() 1915.10 2100.70
52 WK LOW / HIGH ()1260 2100.7
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1981

Management Info :

Berjis Desai - Chairman Satish Mehta - Managing Director

Registered Office :

Address : Plot No. P-1 & P-2,I T - B T Park, Phase- I I,M I D C, Hinjawadi,
Pune,
Maharashtra-411057

Phone : 020-35070033 / 35070000

Website : www.emcure.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
10Aug Emcure Pharmaceuticals gets EIR from U
Emcure Pharmaceuticals has received the Establishment Inspection Report..
10Aug Emcure Pharmaceuticals moves up on get
Emcure Pharmaceuticals is currently trading at Rs. 1987.10, up by 10.00..
21Jul Emcure gets nod to market Poviztra for
Emcure Pharmaceuticals has secured Central Drugs Standard Control Organi..
21Jul Emcure soars on getting nod to market
Emcure Pharmaceuticals is currently trading at Rs. 1909.50, up by 48.80..
14Jul Emcure Pharmaceuticals to acquire rema
Emcure Pharmaceuticals has inked pact to acquire remaining 12.05% stake..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit2001.087329.59
Gross Profit 2686.73 9441.91
Operating Profit 3646.1513342.66
Net Sales 14509.3152431.88
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27273.30 (5.26%)
M.Cap ( in Cr)
57953.86
Neuland Laboratories (BSE)
 22875.70 (0.97%)
M.Cap ( in Cr)
29349.27
Alkem Laboratories (BSE)
 5501.60 (3.03%)
M.Cap ( in Cr)
65779.88
Caplin Point Labs. (BSE)
 2747.85 (5.87%)
M.Cap ( in Cr)
20886.87
Acutaas Chemicals (BSE)
 3438.15 (3.70%)
M.Cap ( in Cr)
28148.52
Shareholding Pattern
PROMOTERS 77.83%
NON-INSTITUTION 8.83%
MUTUAL FUNDS/UTI 6.87%
FI/BANKS/INSURANCE 1.34%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74294.96-19.63 (-0.03%)
NIFTY23346.4075.80 (0.33%)
Dow Jones 51682.64-95.40 (-0.18%)
Nasdaq 26522.54104.24 (0.39%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI